ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation.

Lin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.